Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT00925327
Eligibility Criteria:
Inclusion Criteria:
* Age 6 to 18 years
* Having a diagnosis of progressive keratoconus
* Signed written informed consent
* Having a condition that limits the patient's capacity to comply with the cross-linking treatment procedures and/or the diagnostic tests and measurements required by the ongoing clinical studies
* Willingness and ability to comply with schedule for follow-up visits
Exclusion Criteria:
* Corneal pachymetry at the screening exam that is \<400 microns at the thinnest point
* Previous ocular condition in the eye(s) to be treated that may predispose the eye for future complications, for example (herpes simplex, herpes zoster keratitis, recurrent erosion syndrome, corneal melt, or corneal dystrophy, etc.)
* A history of delayed epithelial healing in the eye(s) to be treated
* Pregnancy or lactation during the course of the study
* A known sensitivity to study medications
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
18 Years
Study:
NCT00925327
Study Brief:
Protocol Section:
NCT00925327